Concepedia

Publication | Open Access

A phase II trial of a multi‐agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer

DOIFull Paper Access

149

Citations

24

References

2013

Year

Nathan Robison, Federico Campigotto, Peter Manley, Christopher D. Turner, Mary Ann Zimmerman, Christine Chordas, Annette M. Werger, Jeffrey C. Allen, Stewart Goldman, Joshua B. Rubin,
Pediatric Blood & Cancer

Abstract

The 5-drug regimen was well tolerated. Clinical activity was demonstrated in some but not all tumor strata.

References

YearCitations

Page 1